These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 2068562

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of oral and intravenous defibrotide on blood viscosity in patients with peripheral obliterative arterial disease.
    Belfiglio A, Traietti P, Bologna E, Salvo G.
    Clin Ther; 1989; 11(4):479-84. PubMed ID: 2776165
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells.
    Falanga A, Vignoli A, Marchetti M, Barbui T.
    Leukemia; 2003 Aug; 17(8):1636-42. PubMed ID: 12886253
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical evaluation of short-term defibrotide treatment of patients with atherosclerosis obliterans of the lower limbs.
    Avellone G, Mandalà V, Pinto A, Martino A, Strano A.
    Haemostasis; 1986 Aug; 16 Suppl 1():55-8. PubMed ID: 2423422
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C.
    Clin Trials Metaanal; 1994 Apr; 29(1):21-30. PubMed ID: 10150182
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Defibrotide affects the anticoagulant and lipase-releasing activities of heparin.
    Porta R, Pescador R, Mantovani M, Prino G.
    Haemostasis; 1990 Apr; 20(6):347-56. PubMed ID: 2099323
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Evolution of superficial vein thrombosis treated with defibrotide: comparison with low dose subcutaneous heparin.
    Belcaro G.
    Int J Tissue React; 1990 Apr; 12(5):319-24. PubMed ID: 2098372
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A pilot evaluation of the effects of defibrotide in patients affected by acute myocardial infarction.
    Carelli M, Citone C, Di Marcotullio G, Giampaolo P, Malinconico U, Polizzi C, Dell'Edera N, Gambelli GC, Cornelli U, Milazzotto F.
    Semin Thromb Hemost; 1988 Apr; 14 Suppl():71-6. PubMed ID: 3194768
    [No Abstract] [Full Text] [Related]

  • 37. [Defibrotide: a new antithrombotic agent].
    Bán A.
    Orv Hetil; 2001 Jun 03; 142(22):1193-4. PubMed ID: 11424595
    [No Abstract] [Full Text] [Related]

  • 38. Investigation of the fibrinolytic activity of defibrotide fractions.
    Hizal N, Bilsel S, Emerk K.
    Gen Pharmacol; 1994 Dec 03; 25(8):1617-20. PubMed ID: 7721037
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of Defibrotide and of its profibrinolytic activity in the rabbit.
    Pescador R, Mantovani M, Prino G, Madonna M.
    Thromb Res; 1983 Apr 01; 30(1):1-11. PubMed ID: 6687960
    [Abstract] [Full Text] [Related]

  • 40. Usefulness of defibrotide in the treatment of vascular disorders: a clinical-pharmacologic study.
    Di Perri T, Laghi-Pasini F, Frigerio C, Capecchi PL, Messa G, Franchi M, Landini F, Burresi A, Caccatelli L, Ghezzi A.
    Semin Thromb Hemost; 1991 Apr 01; 17 Suppl 1():85-95. PubMed ID: 1648793
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.